Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Vivek Shah

Adult Reconstructive Orthopaedic Surgery Boston, MA Medical Doctor

NPI 1164611687 CMS profile 233899

750 Washington St, Boston, MA 02111

Open in the dashboard

General payments

$1,449,216

1,514 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Vivek Shah of Boston, MA is reported in the CMS Open Payments database as having received $1,449,216 across 1,514 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Adult Reconstructive Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $261,778 222
2024 General $255,083 243
2023 General $317,274 274
2022 General $229,263 256
2021 General $172,035 218
2020 General $98,384 119
2019 General $115,398 182

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Vivek Shah
  • Adult Reconstructive Orthopaedic Surgery median
  • Middle half of Adult Reconstructive Orthopaedic Surgery
  • National median

In program year 2025, general payments to Vivek Shah were reported at $261,778. Among 1,079 Adult Reconstructive Orthopaedic Surgery profiles paid that year, the median was $1,406 and the middle half received between $318 and $8,709.

Show as a table
Year Vivek Shah Adult Reconstructive Orthopaedic Surgery median Middle half National median
2019 $115,398 $1,416 $292–$9,336 $163
2020 $98,384 $647 $141–$6,474 $114
2021 $172,035 $1,073 $211–$6,497 $132
2022 $229,263 $1,217 $236–$6,299 $149
2023 $317,274 $1,082 $246–$6,818 $160
2024 $255,083 $1,575 $323–$8,944 $164
2025 $261,778 $1,406 $318–$8,709 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $1,209,107 1,274 payments
  2. DePuy Synthes Products, Inc. $98,215 58 payments
  3. Medacta USA, Inc. $56,408 58 payments
  4. Encore Medical, LP $49,360 48 payments
  5. Medical Device Business Services, Inc. $12,173 18 payments
  6. Ignite Orthomotion LLC $9,407 3 payments
  7. Uoc USA Inc $6,803 8 payments
  8. Insight Medical Systems, Inc. $3,900 5 payments
  9. Stryker Corporation $1,171 20 payments
  10. Orthalign Inc $1,105 8 payments
  11. Other $1,567 14 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $917,589 322 payments
  2. Education $379,931 102 payments
  3. Travel and Lodging $117,596 510 payments
  4. Food and Beverage $31,600 578 payments
  5. Honoraria $2,500 2 payments
Products named General payments · program years 2019–2025
  1. Oxford Knees $262,294 227 payments
  2. Persona $254,035 277 payments
  3. Arcos $208,650 117 payments
  4. Avenir Hips $134,614 104 payments
  5. G7 $109,619 61 payments
  6. Persona Revision $71,989 68 payments
  7. ATTUNE $52,785 31 payments
  8. Oxford-Knees $42,539 40 payments
  9. Avenir Hips $41,926 58 payments
  10. Oxford Knees $40,824 53 payments
  11. Other $345,640 496 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 25 billing codes

Paid by Medicare

$309,305

Medicare's payments for the services billed

Medicare patients

553

Average age 74

Services billed

788

359 women, 194 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 68%
Depression 22%
Ischemic heart disease 21%
Osteoporosis 20%
Diabetes 17%
Chronic kidney disease 17%
Atrial fibrillation 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

1,514 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Adult Reconstructive Orthopaedic Surgery in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record